| NCT06731075 | A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. | NOT_YET_RECRUITING | PHASE3 | 2025-12-15 | 2027-05-22 | 2027-04-25 |
| NCT04754334 | A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus | TERMINATED | PHASE3 | 2021-03-16 | 2023-01-13 | 2023-01-13 |
| NCT04616014 | A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) | COMPLETED | PHASE2 | 2021-03-01 | 2022-09-15 | 2022-07-01 |
| NCT04606576 | Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus | TERMINATED | PHASE3 | 2020-12-15 | 2023-01-13 | 2023-01-13 |
| NCT04618744 | A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) | COMPLETED | PHASE2 | 2020-11-24 | 2022-06-27 | 2022-06-27 |
| NCT04564846 | A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2020-11-23 | 2022-06-07 | 2022-06-07 |
| NCT04150107 | A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes | COMPLETED | PHASE2 | 2019-10-17 | 2020-03-12 | 2020-02-06 |
| NCT02653300 | A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) | COMPLETED | PHASE2 | 2018-09-20 | 2020-04-01 | 2020-03-01 |
| NCT03467932 | A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2018-05-29 | 2020-02-18 | 2019-10-21 |
| NCT02954601 | A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2016-10 | 2017-03-15 | 2017-02-24 |
| NCT02496000 | Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 | 2015-07-27 | 2016-09-13 | 2016-06-27 |
| NCT02094534 | A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics | COMPLETED | PHASE2 | 2014-03 | 2014-10 | 2014-08 |
| NCT01889667 | Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE2 | 2013-06 | 2013-11 | 2013-11 |